gvtcx

Provision of pre-Validated CLL gene panel

BIRMINGHAM WOMENS AND CHILDRENS NHS FOUNDATION TRUST Published 16 Apr 2021 Contracts Finder

key details

Statuscomplete
Category (CPV) 33000000
RegionWest Midlands
Deadline10 Mar 2021
Contract start13 Mar 2021
Contract end30 Aug 2021
Proceduredirect
SME suitableNo
OCIDocds-b5fd17-c0563a22-8789-497f-958a-60293a99e61e

Award

SupplierValueDateStatus
OXFORD GENE TECHNOLOGY £28,330 12 Mar 2021 active

description

Provision of hybridisation-based NGS enrichment panel for CLL, pre-validated product compatible with MiSeq sequencing platforms

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
16 Apr 2021 Award (award) · 0c381c93-756e-4cb4-8e13-4a9fbebc7277-429144

more from BIRMINGHAM WOMENS AND CHILDRENS NHS FOUNDATION TRUST

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.